
BGI Genomics Co., Ltd. — Investor Relations & Filings
BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于持股5%以上股东工商登记事项变更的公告 | 2019-10-11 | Chinese | |
| 关于控股股东一致行动人部分股权质押的公告 | 2019-09-26 | Chinese | |
| 关于向合格投资者公开发行公司债券获得中国证监会核准批复的公告 | 2019-09-20 | Chinese | |
| 关于持股5%以上股东参与认购基金份额结果暨减持计划实施完成公告 | 2019-09-18 | Chinese | |
| 关于青岛华大基因健康医疗产业园投资进展暨全资子公司签订拍卖出让成交确认书的公告 | 2019-09-17 | Chinese | |
| 2019年第四次临时股东大会之法律意见书 | 2019-09-12 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 38348951 | 关于持股5%以上股东工商登记事项变更的公告 | 2019-10-11 | Chinese | ||
| 38348946 | 关于控股股东一致行动人部分股权质押的公告 | 2019-09-26 | Chinese | ||
| 38348940 | 关于向合格投资者公开发行公司债券获得中国证监会核准批复的公告 | 2019-09-20 | Chinese | ||
| 38348931 | 关于持股5%以上股东参与认购基金份额结果暨减持计划实施完成公告 | 2019-09-18 | Chinese | ||
| 38348918 | 关于青岛华大基因健康医疗产业园投资进展暨全资子公司签订拍卖出让成交确认书的公告 | 2019-09-17 | Chinese | ||
| 38348910 | 2019年第四次临时股东大会之法律意见书 | 2019-09-12 | Chinese | ||
| 38348901 | 2019年第四次临时股东大会决议公告 | 2019-09-12 | Chinese | ||
| 38348889 | 关于召开2019年第四次临时股东大会的提示性公告 | 2019-09-09 | Chinese | ||
| 38348870 | 关于公司及控股子公司参与起草的国家标准获批发布的公告 | 2019-09-05 | Chinese | ||
| 38348853 | 关于参加2019年深圳上市公司投资者网上集体接待日活动的公告 | 2019-08-30 | Chinese | ||
| 38348841 | 关于全资子公司取得医疗器械注册证的公告 | 2019-08-30 | Chinese | ||
| 38348836 | 中信证券股份有限公司关于公司受让南京华大共赢一号创业投资企业(有限合伙)财产份额暨关联交易的核查意见 | 2019-08-27 | Chinese | ||
| 38348818 | 关于受让南京华大共赢一号创业投资企业(有限合伙)财产份额暨关联交易的公告 | 2019-08-27 | Chinese | ||
| 38348803 | 关于增加公司及下属子公司2019年度银行综合授信额度并提供担保的公告 | 2019-08-27 | Chinese | ||
| 38348793 | 2019年半年度报告摘要 | 2019-08-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BGI Genomics Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55655/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55655 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55655 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55655 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55655}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BGI Genomics Co., Ltd. (id: 55655)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.